Download interactions: TXT MITAB-2.5
| Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
|---|---|---|---|---|---|---|
|
BTK
Tyrosine-protein kinase BTK |
2 |
20 |
Small-scale |
0.778 | High |
|
|
P85A
Phosphatidylinositol 3-kinase regulatory subunit alpha |
2 |
20 |
Small-scale |
0.754 | High |
|
|
BLNK
B-cell linker protein |
2 |
20 |
Small-scale |
0.754 | High |
|
|
STAT3
Signal transducer and activator of transcription 3 |
1 |
15 |
Small-scale |
0.647 | High |
|
|
GBB1
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 |
1 |
6 |
Small-scale |
0.618 | High |
|
|
PLCG2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 |
1 |
16 |
Small-scale |
0.618 | High |
|
|
SHIP1
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 |
1 |
20 |
Small-scale |
0.618 | High |
|
|
WASP
Actin nucleation-promoting factor WAS |
2 |
20 |
Small-scale |
0.596 | High |
|
|
GRB2
Growth factor receptor-bound protein 2 |
1 |
20 |
High-throughput |
0.590 | High |
|
|
MYD88
Myeloid differentiation primary response protein MyD88 |
1 |
15 |
Small-scale |
0.536 | High |
|
|
TCAM1
TIR domain-containing adapter molecule 1 |
1 |
8 |
Small-scale |
0.536 | High |
|
|
TNR5
Tumor necrosis factor receptor superfamily member 5 |
1 |
12 |
Small-scale |
0.515 | High |
|
|
E9Q604
Integrin alpha M |
1 |
6 |
High-throughput |
0.501 | High |
|
|
CD19
B-lymphocyte antigen CD19 |
1 |
2 |
Small-scale |
0.479 | High |
|
|
GBG2
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 |
1 |
3 |
Small-scale |
0.479 | High |
|
|
TRAF3
TNF receptor-associated factor 3 |
1 |
20 |
Small-scale |
0.479 | High |
|
|
ARI3A
AT-rich interactive domain-containing protein 3A |
1 |
1 |
Small-scale |
0.479 | High |
|
|
Q9ERL0
Btk-PH-domain binding protein |
1 |
3 |
Small-scale |
0.479 | High |
|
|
IRF2
Interferon regulatory factor 2 |
1 |
0 |
Small-scale |
0.458 | High |
|
|
CKLF3
CKLF-like MARVEL transmembrane domain-containing protein 3 |
1 |
0 |
Small-scale |
0.458 | High |
|
|
PIN1
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
1 |
0 |
Small-scale |
0.458 | High |
|
|
ALDOA
Fructose-bisphosphate aldolase A |
1 |
1 |
High-throughput |
0.457 | High |
|
|
H2AZ
Histone H2A.Z |
1 |
1 |
High-throughput |
0.457 | High |
|
|
FRIL1
Ferritin light chain 1 |
1 |
2 |
High-throughput |
0.457 | High |
|
|
SMBP2
DNA-binding protein SMUBP-2 |
1 |
1 |
High-throughput |
0.457 | High |
|
|
PP2BB
Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform |
1 |
2 |
High-throughput |
0.457 | High |
|
|
EF1A2
Elongation factor 1-alpha 2 |
1 |
2 |
High-throughput |
0.457 | High |
|
|
ACTC
Actin, alpha cardiac muscle 1 |
1 |
5 |
High-throughput |
0.457 | High |
|
|
TBA1A
Tubulin alpha-1A chain |
1 |
10 |
High-throughput |
0.457 | High |
|
|
CBX1
Chromobox protein homolog 1 |
1 |
5 |
High-throughput |
0.457 | High |
|
|
PPM1G
Protein phosphatase 1G |
1 |
1 |
High-throughput |
0.457 | High |
|
|
DDX5
Probable ATP-dependent RNA helicase DDX5 |
1 |
2 |
High-throughput |
0.457 | High |
|
|
MRC1
Macrophage mannose receptor 1 |
1 |
4 |
High-throughput |
0.457 | High |
|
|
KCMF1
E3 ubiquitin-protein ligase KCMF1 |
1 |
7 |
High-throughput |
0.457 | High |
|
|
PFKAP
ATP-dependent 6-phosphofructokinase, platelet type |
1 |
3 |
High-throughput |
0.457 | High |
|
|
MA2B1
Lysosomal alpha-mannosidase |
1 |
0 |
High-throughput |
0.438 | High |
|
|
RL7
Large ribosomal subunit protein uL30 |
1 |
0 |
High-throughput |
0.438 | High |
|
|
GLNA
Glutamine synthetase |
1 |
0 |
High-throughput |
0.438 | High |
|
|
LC7L3
Luc7-like protein 3 |
1 |
0 |
High-throughput |
0.438 | High |
|
|
SMCE1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 |
1 |
4 |
High-throughput |
0.417 | High |
|
|
AP3B1
AP-3 complex subunit beta-1 |
1 |
6 |
High-throughput |
0.417 | High |
|
|
LYOX
Protein-lysine 6-oxidase |
1 |
0 |
High-throughput |
0.238 | Low |
|
|
Q8BTX4
Ribosome biogenesis protein NOP53 |
1 |
0 |
High-throughput |
0.238 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024
